SCHEMBL6502267

SCHEMBL6502267

CN(C)c1ccc(C=CC(=O)O)c(Cl)c1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA4 P22748 2/20 0.40
NFKB1 P19838 1/20 0.40
MIF P14174 1/20 0.39
KDM4E B2RXH2 1/20 0.38
MAPK1 P28482 1/20 0.38
MAPT P10636 3/20 0.37
PTGER3 P43115 3/20 0.37
PTGER2 P43116 3/20 0.37
PTGER1 P34995 2/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
POLB P06746 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HCAR2 Q8TDS4 2/20 0.36
HDAC3 O15379 1/20 0.36
TNKS O95271 1/20 0.36
HDAC4 P56524 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6503055 1.00 CA1 (0.40) CA1CA2CA4NFKB1MIF
SCHEMBL3954647 0.77 PTGER3 (0.49) CA1CA2CA4NFKB1MIF
SCHEMBL8296729 0.75 CA1 (0.44) CA1CA2CA4NFKB1MIF
SCHEMBL16048819 0.75 CA1 (0.53) CA1CA2CA4NFKB1MIF
SCHEMBL16048816 0.75 CA1 (0.53) CA1CA2CA4NFKB1MIF
SCHEMBL7455794 0.74 CA1 (0.56) CA1CA2CA4NFKB1KDM4E
SCHEMBL8296698 0.74 MIF (0.54) CA1CA2CA4NFKB1MIF
SCHEMBL6568835 0.74 CA1 (0.43) CA1CA2CA4NFKB1MIF
SCHEMBL6561859 0.74 CA1 (0.56) CA1CA2CA4NFKB1KDM4E
SCHEMBL6240290 0.73 ITGB2 (0.43) CA1CA2CA4NFKB1MIF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005102390-A2 COMBINATIONS COMPRISING ALPHA-2-DELTA LIGANDS AND NMDA RECEPTOR ANTAGONISTS PFIZER JAPAN, INC. (JP) 2005-11-03 WO disclosed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed